Evidence map›Paper›PMID 29721053›Full record

ArticleJournal of Cancer2018

Survivorship and Advocacy in Inflammatory Breast Cancer.

Angela Alexander, Terry Lynn Arnold, Sandra Bishnoi, Caroline Ballinger, Simona F Shaitelman, Mark V Schaverien, Lorenzo Cohen, Mary Dev, Naoto T Ueno

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Angela AlexanderDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX.
Terry Lynn ArnoldThe IBC Network Foundation.
Sandra BishnoiRice 360 Program, Rice University, Houston TX.
Caroline BallingerThe IBC Network UK.
Simona F ShaitelmanDepartment of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston TX.
Mark V SchaverienDepartment of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston TX.
Lorenzo CohenIntegrative Medicine Program, The University of Texas MD Anderson Cancer Center, Houston TX.
Mary DevDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX.
Naoto T UenoDepartment of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In February 2017, the Morgan Welch Inflammatory Breast Cancer (IBC) Research Program and Clinic hosted a scientific conference in Houston to commemorate the tenth anniversary of the opening of the first IBC-dedicated clinic in the world. Attendees included basic science researchers, clinicians who treat IBC, as well as patients and their caregivers. Several US-based and international IBC-focused nonprofit organizations were also represented. In this third paper from the conference, we report on the breakout session regarding survivorship and advocacy issues related to IBC, sharing an overview of the educational content presented and discussions regarding the future of IBC advocacy. Panelists focused on lymphedema research and clinical solutions, integrative medicine, and social work, with time provided for questions in small groups. IBC nonprofits that are leading advocacy efforts were introduced, and ways to become involved in these initiatives were discussed. Priorities for future advocacy and clinical care needs were also highlighted. In addition to summarizing these topics, we provide a suggested integrated IBC-specific plan of care that could be provided to the patient at the beginning of care and referred to throughout treatment and follow-up.

Indexed as

AdvocacyFollow-upInflammatory breast cancerLymphedemaPatientsSurvivorship needs

Identifiers

PMID29721053
PMCPMC5929088

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.